Download PDF
1 / Pages

Other users also viewed these articles

Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients A Burak-Leipuner; F García-Gorrosquieta; N Uribe-Rivera; A Servín-Caamaño; JA Romero-Bermúdez; LE Ceceña-Martínez; P Alagón-Fernández del Campo; FY Vargas-Duran; AK Soto-Martinez; CI Hinojosa-Segura; D Montemira-Orozco; JL Perez-Hernández; G Alexanderson-Rosas; F Higuera-de la Tijera;
Ann Hepatol. 2022;27 Supl 3:
Epidemiologic profile of non-alcoholic fatty liver disease in apparently healthy blood bank donors JE Lira-Vera; O Morales-Gutiérrez; FY Vargas-Durán; P Alagón-Fernández del Campo; AK Soto Martínez; D Montemira-Orozco; A Burak-Leipuner; C Hinojosa-Segura; G Gutiérrez-Reyes; M Martínez-Castillo; S Sánchez-Valle; MA Lemus-Peña; D Montes de Oca-Ángeles; A Hernández-Barragán; M Hernández-Santillán; MF Higuera-de la Tijera; YL Béjar-Ramírez; JL Pérez-Hernández;
Ann Hepatol. 2022;27 Supl 3:
Prevalence of non-alcoholic fatty liver disease in apparently healthy blood bank donors: metabolic, alcohol, and combined damage JE Lira-Vera; O Morales-Gutiérrez; FY Vargas-Durán; P Alagón-Fernández del Campo; AK Soto Martínez; D Montemira-Orozco; A Burak-Leipuner; C Hinojosa-Segura; G Gutiérrez-Reyes; M Martínez-Castillo; S Sánchez-Valle; MA Lemus-Peña; D Montes de Oca-Ángeles; A Hernández-Barragán; M Hernández-Santillán; MF Higuera-de la Tijera; YL Béjar-Ramírez; JL Pérez-Hernández;
Ann Hepatol. 2022;27 Supl 3: